Literature DB >> 576878

Bioavailability of 11 phenytoin products.

A P Melikian, A B Straughn, G W Slywka, P L Whyatt, M C Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 576878     DOI： 10.1007/bf01066217

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  8 in total

1.  Bioavailability of diphenylhydantoin.

Authors:  K S Albert; E Sakmar; M R Hallmark; D J Weidler; J G Wagner
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

2.  Blood phenytoin concentrations produced by ingestion of three different phenytoin preparations.

Authors:  D B Appleton; M J Eadie; W D Hooper; B Lucas; J M Sutherland; J H Tyrer
Journal:  Med J Aust       Date:  1972-02-26       Impact factor: 7.738

3.  Diphenylhydantoin.

Authors:  A J Glazko
Journal:  Pharmacology       Date:  1972       Impact factor: 2.547

4.  Determination of the pKa' value for 5,5-diphenylhydantoin.

Authors:  S P Agarwal; M I Blake
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

5.  Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.

Authors:  H J Kupferberg
Journal:  Clin Chim Acta       Date:  1970-08       Impact factor: 3.786

6.  Gas chromatography of barbiturates, phenolic alkaloids, and xanthine bases: flash-heater methylation by means of trimethylanilinium hydroxide.

Authors:  E Brochmann-Hanssen; T O Oke
Journal:  J Pharm Sci       Date:  1969-03       Impact factor: 3.534

7.  Relative bioavailability of commercial ampicillin formulations in man.

Authors:  M Mayersohn; L Endrenyi
Journal:  Can Med Assoc J       Date:  1973-11-17       Impact factor: 8.262

8.  Comparative bioavailability of three brands of ampicillin.

Authors:  C MacLeod; H Rabin; J Ruedy; M Caron; D Zarowny; R O Davies
Journal:  Can Med Assoc J       Date:  1972-08-05       Impact factor: 8.262
  8 in total
  4 in total

1.  A comparison between microcrystalline and conventional phenytoin preparations: relative bioavailability and steady-state plasma concentrations.

Authors:  L O Boréus; A Nergårdh; M Ehrnebo; K Theorell
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

2.  Rate of phenytoin accumulation in man: a simulation study.

Authors:  T M Ludden; J P Allen; L W Schneider; S A Stavchansky
Journal:  J Pharmacokinet Biopharm       Date:  1978-10

3.  Is saliva suitable as a biological fluid in relative bioavailability studies? Analysis of its performance in a 4 x 2 replicate crossover design.

Authors:  M Esperanza Ruiz; Pietro Fagiolino; Perla M de Buschiazzo; M Guillermina Volonté
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-06-30       Impact factor: 2.441

4.  Comparative bioavailability and in-vitro antimicrobial activity of two different brands of rifampicin.

Authors:  S K Garg; A Chakrabarti; D Panigrahi; M Sharma; P Talwar; N Kumar; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.